First 5 available interviews from San Antonio Breast Cancer Symposium 2006
 

http://www.breastcancerupdate.com/do.../8/default.asp

Several interesting comments including speculation on the potential for high response to the Herceptin+Tykerb combo based on preclinical & early clinical results ( track 17 of Interview with Lisa Carey, MD and Jenny C Chang, MD:
Potential synergy between trastuzumab and lapatinib)
Also track 13:Receptor cross talk and potential changes in ER or HER2 phenotype